Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Cardiac Electrophysiologists (US)

Articles with lock require a subscription to GLG News | Request a free trial
May 20, 2008
A new drug that would change the way we treat Atrial Fibrillation!
Analysis of: Landmark ATHENA Study findings with dronedarone presented during the annual Heart Rhythm meeting in San Francisco | www.medscape.com
Author: Nassir Marrouche, Director of Cardiac Electrophysiology Laboratories, University of Utah Health Sciences Center
Atrial fibrillation management.  New anti-arrhythmic medication.  
Brian OlshanskyMarch 5, 2008
The Future of Stereotaxis
Analysis of: Stereotaxis shares tank on Q4 loss | www.24x7mag.com
Author: Brian Olshansky, Professor of Medicine, University of Iowa Hospitals and Clinics
The development of the new technology related to Stereotaxis has been slow going.  While there is much hope there is also much hype.  It is not clear that Stereotaxis really adds much to the success of catheter ablation of atrial fibrillaiton.  There has been a vocal minority...
Daniel WeissOctober 18, 2007
Medtronic - the new Guidant?
Analysis of: Medtronic Pulls Heart Device Wires | www.thestreet.com
Author: Daniel Weiss, Chief Medical Officer, Vicor Technologies, Inc.
The current recall is yet another in the world of cardiac rhythm devices. The ICD market is already shakey and may be adversely affected. Will Medtronic's reputation suffer?
October 17, 2007
Another ICD Related Recall - The Medtronic Fidelis ICD Lead: Increase in Fractures
Analysis of: Patients Warned as Maker Halts Sale of Heart Implant Part | www.nytimes.com
Author: GLG Expert Contributor
With the industry still struggling to recover from the relatively recent Guidant ICD recalls it is possible that this latest ICD lead recall will affect overall ICD implant rates.  It is also possible that Medtronic, the leader in the ICD market, will suffer a loss of market share due to this latest...
September 27, 2007
Products to round out St. Jude's Product Line
Analysis of: St. Jude Medical Announces FDA Approval Of Company's First Radiofrequency Wireless ICD And CRT-D Heart Failure Devices | www.medicalnewstoday.com
Author: GLG Expert Contributor
These products bring St. Jude in Line with Medtronic and Boston Scientific in offering a Wireless platform for their ICD and CRT-D line. The other features listed were generally available in their prior generation of devices, thus do not offer any new capabilities.
September 21, 2007
GSK and Astra-Zeneca to have big losses in marketshare with generic carvedilol on market
Analysis of: FDA Approves First Generic Versions of Coreg | www.fda.gov
Author: GLG Expert Contributor
Market impact is huge for many reasons. First, carvedilol is postulated to be a more effective beta blocker in the management of CHF with reduced ejection fraction compared to other generics and name brand ones on the market. This is based on a number of clinical trials demonstrating superiority in...
Daniel WeissSeptember 17, 2007
TB-402 - the type of anticoagulant patients and physicians are looking for as a warfarin replacement
Analysis of: ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-402 | www.pipelinereview.com
Author: Daniel Weiss, Chief Medical Officer, Vicor Technologies, Inc.
TB-402 is a new anticoagulant candidate that seeks to fill a desperate unmet need in a variety of different medical conditions. It would be easily administered with a low risk of patient noncompliance, have reversible effects, and potentially safer than currently available alternatives.
August 28, 2007
Medical Tourism
Analysis of: American's Gamble for Bargain Surgery Abroad | www.medpagetoday.com
Author: GLG Expert Contributor
Medical Tourism is purely linked to lower costs for the same procedure.Most of these relate to 1)Small elective surgeries 2) Non-Urgent Cardiac and Non-Cardiac Procedures and Operations 3)Cosmetic Procedures 4)Dental and Vision corrective procedures 5)Radiologic Procedures(Diagnostic and Ther...
August 28, 2007
Angio-seal today-SS
Analysis of: St. Jude Medical Announces Japanese Approval Of The Angio-Seal STS Plus Vascular Closure Device | www.medicalnewstoday.com
Author: GLG Expert Contributor
The key implications remain 1)Safety 2)Efficacy 3)Cost 4)Complications e)Outcome analysis
August 9, 2007
A 3-tiered healthcare system
Analysis of: MDs offer new services, for $3,600 yearly fee | www.boston.com
Author: GLG Expert Contributor
1) Healthcare in America is becoming a 3 tiered system the insured, the uninsured and the insured "plus" 2) Most definitive care in the US is performed by specialists 3) NPs and PAs can perform the role of PCP for most patients.

Page : 1 2 3 Next1 to 10 of 21

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-01T13:45:22.747